 The first thing that became clear to us when the confinement started is that we had to make an extra effort to be even closer to our stakeholders. So the idea of the webinars came to the director, he launched in one meeting and in the same afternoon I start activating myself, being in contact with the ICT colleagues and the communication colleagues and together in an amazingly quick exchange of activities and actions we launched the first one with the help of members of the scientific committee. And then the same afternoon we launched the registration links. We realized that we had over exceeded the maximum amount of people allowed so we had very quickly to change the license to allow more people. And then we touched different topics linked with COVID-19 like treatment services, prevention services, drug markets and then the recession. But because our aim was to engage our stakeholders I invited one. Tony has attended the majority of the webinars and I would like to hear from him what was the experience as an attendant to the webinars. Thank you Marika. I think obviously you mentioned the confinement and the restrictions that we were all living under. And obviously living and working in isolation you want to keep engaged. You want to hear what's going on within the addiction field, the drugs field. And you know you're looking around, the best way is to look online and then you're looking for something that is, I suppose valuable to you. And the EMCDEA webinars really jumped out with me as a leader of a harm of Irish harm reduction NGO working at the cold face around drugs and drug addiction. And I suppose also we are a civil society organisation engaged with policy structures. So the EMCDEA webinar series has been an important means of keeping me and my colleagues informed of developments in the sector. So that was really, really important to us. It's clear to be inputs from experienced drug service providers and other experts. And I think the audience gets to hear about the issues and in the Q&A, they get to, they get the Q&A section, they get to further question and sort of satisfy themselves on some of the subjects that they're interested in. And I guess I just wanted to say something else about, as well as whether you're a drug policy aficionado or whether you're just interested in all areas of drug policy or whether you're someone who is interested in a specific area of drug policy. I do think that within the existing recordings that the EMCDEA have done and the scheduled upcoming webinars that are yet to be made, I think people will find something to interest them. And all I want to say is keep up the great work at the EMCDEA because you are keeping people engaged and informing people. We really need to learn from each other and the webinars are excellent for that.